LIVER FAT
Clinical trials for LIVER FAT explained in plain language.
Never miss a new study
Get alerted when new LIVER FAT trials appear
Sign up with your email to follow new studies for LIVER FAT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Fatty liver fix? growth hormone drug shows promise in early trial
Disease control CompletedThis study tested a drug called tesamorelin, which boosts growth hormone, in 51 obese adults with nonalcoholic fatty liver disease (NAFLD). The goal was to see if it could lower liver fat and improve liver inflammation and scarring. Participants received either tesamorelin or a p…
Matched conditions: LIVER FAT
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Computer nudge boosts liver referrals in fatty liver study
Knowledge-focused CompletedThis study tested whether a pop-up alert in the electronic medical record could help doctors refer patients with fatty liver disease (NASH) to a liver specialist. Thirty doctors from internal medicine, family medicine, and endocrinology took part. The goal was to see if the alert…
Matched conditions: LIVER FAT
Phase: NA • Sponsor: University of Kansas Medical Center • Aim: Knowledge-focused
Last updated May 17, 2026 05:04 UTC